HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joan Maymó Selected Research

Methotrexate (Mexate)

5/2004Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joan Maymó Research Topics

Disease

6Rheumatoid Arthritis
01/2016 - 06/2010
2Inflammation (Inflammations)
01/2018 - 01/2018
2Axial Spondyloarthritis
04/2016 - 09/2015
2Synovitis
06/2010 - 05/2004
1Sacroiliitis
04/2016
1Infections
05/2014
1Tenosynovitis
06/2010
1Arthritis (Polyarthritis)
05/2004
1Psoriatic Arthritis
05/2004

Drug/Important Bio-Agent (IBA)

2Infliximab (Remicade)FDA Link
04/2016 - 05/2004
1Adalimumab (Humira)FDA Link
04/2016
1AntibodiesIBA
04/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Rheumatoid FactorIBA
01/2016
1CytokinesIBA
09/2015
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
1Rituximab (Mabthera)FDA Link
05/2014
1DNA (Deoxyribonucleic Acid)IBA
05/2013
1C-Reactive ProteinIBA
06/2010
1Antirheumatic Agents (DMARD)IBA
06/2010
1GadoliniumIBA
06/2010
1Etanercept (Enbrel)FDA Link
06/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2004
1Methotrexate (Mexate)FDA LinkGeneric
05/2004

Therapy/Procedure

4Therapeutics
01/2015 - 05/2004
2Injections
01/2018 - 01/2018
2Drug Tapering
04/2016 - 09/2015
2Aftercare (After-Treatment)
05/2014 - 06/2010
1Biological Therapy
05/2013